NOVEL METHOD FOR QUANTIFYING HEPATIC STEATOSIS IN PATIENTS WITH METABOLICALLY ASSOCIATED FATTY LIVER DISEASE

Author:

Borsukov A.1ORCID,Venidiktova D.1ORCID,Borsukov S.1ORCID

Affiliation:

1. Fundamental research laboratory “Diagnostic researches and minimally invasive technologies” of Smolensk State Medical University, the Ministry of Health of the Russian Federation

Abstract

Introduction. The article presents an overview of novel complex algorithm based on methods of ultrasound steatometry, combined elastography and dual-energy X-ray absorbtiometry in “Whole body” mode in diagnostic and monitoring of metabolically associated fatty liver disease.The purpose of the study: to assess the possibility of quantitative ultrasound steatometry using in the detection and monitoring of metabolically associated fatty liver disease.Material and methods. 157 patients were examined. The main group consisted of 47 patients with liver steatosis; 45 patients with steatohepatitis and clinically insignificant liver fibrosis (F0-F1); 32 patients with steatohepatitis and clinically significant liver fibrosis (F2-F3); 33 patients with focal hepatic steatosis. We used complex algorithm based on methods of questionnaires, laboratory tests, ultrasound steatometry, combined elastography and dual-energy x-ray absorbtiometry in “Whole body” mode, liver biopsy. to determine the severity of steatosis, a scale was used: S0 – no steatosis; 2.9 dB/cm.Results and conclusion. It is possible to use quantitative ultrasound steatometry for metabolically associated fatty liver disease, as a reference method both for the initial detection of the disease and for monitoring non-drug treatment (sensitivity 90.7%, specificity 92.4%). The optimal complex for the diagnosis and monitoring of non-drug treatment of metabolically associated fatty liver disease includes an assessment of the level of compliance, the use of quantitative ultrasound steatometry and dual-energy X-ray absorptiometry in the «Whole body» mode (sensitivity 92.8%, specificity 92.3%).

Publisher

Alfmed LLC

Reference34 articles.

1. Ivashkin VT, Maevskaya MV, Pavlov CS, et al. Clinical guidelines for the diagnosis and treatment of non-alcoholic fatty liver disease of the Russian Society for the Study of the Liver and the Russian Gastroenterological Association. Russian Journal of Gastroenterology, Hepatology, Coloproctology.– 2016.– T. 26.– No. 2.– P. 24–42. (In Russ.).

2. Lazebnik LB, Golovanova EV, Turkina SV, et al. Non-alcoholic fatty liver disease in adults: clinic, diagnosis, treatment. Recommendations for therapists, third edition. Experimental and clinical gastroenterology. 2021; 185(1): 4–52. DOI: 10.31146/1682–8658-ecg-185-1-4-52 (In Russ.).

3. Zhou, J. Epidemiological Features of NAFLD From1999 to 2018 in China / J. Zhou // Hepatology.– 2020.– V. 71.– No. 5.– P. 1851–1864.

4. O’Neill, S. Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies / S. O’Neill, L. O’Driscoll // Obesity reviews.– 2015.– V. 16.– No. 1.– P. 1–12.

5. Sheveleva MA, Hudyakova NV, Shishkin AN, et al. Non-alcoholic fatty liver disease and metabolic syndrome. Health is the basis of human potential: problems and ways to solve them.– 2019.– T. 14.– No. 2.– P. 632–642. (In Russ.).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3